A one-hit model can be applied to the initiation of APL and CML whereas a two-hit model is more suitable to the initiation of AML with RUNX1-RUNX1T1 and other AMLs. Here, RUNX1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.